Fox Run Management’s Veracyte VCYT Stock Holding History

Fox Run Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-36,596	Closed	-$989K	–	1257
2025 Q2	$989K	Buy	+36,596	New	+$1.06M	0.16%	195
2024 Q4	–	Sell	-9,011	Closed	-$307K	–	1197
2024 Q3	$307K	Sell	9,011 -616	-6%	-$17.3K	0.07%	530
2024 Q2	$209K	Buy	+9,627	New	+$202K	0.04%	665
2024 Q1	–	Sell	-13,746	Closed	-$378K	–	1079
2023 Q4	$378K	Buy	+13,746	New	+$332K	0.1%	414
2023 Q1	–	Sell	-34,145	Closed	-$810K	–	943
2022 Q4	$810K	Buy	+34,145	New	+$794K	0.33%	45
2022 Q1	–	Sell	-7,950	Closed	-$328K	–	713
2021 Q4	$328K	Buy	+7,950	New	+$351K	0.19%	201
2021 Q3	–	Sell	-7,089	Closed	-$283K	–	628
2021 Q2	$283K	Buy	+7,089	New	+$303K	0.26%	183
2021 Q1	–	Sell	-5,570	Closed	-$273K	–	322
2020 Q4	$273K	Buy	+5,570	New	+$258K	0.55%	71

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fox Run Management's VCYT Position: Q3 2025 in Review

Fox Run Management sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 36,596 shares — an estimated $989K sold.

Fox Run Management first reported a position in VCYT in Q4 2020 and held it in 8 quarters. The position peaked at $989K in Q2 2025. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

Fox Run Management reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
Fox Run Management sold 36,596 Veracyte shares in Q3 2025, an estimated $989K.
Fox Run Management first reported a position in Veracyte in Q4 2020 and held it in 8 quarters.
Fox Run Management's Veracyte position peaked at $989K in Q2 2025.
298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.